Stock Taper
SCREENER COMPARE ANY 2 STOCKS
TELA
TELA BIO, INC.
NASDAQ
$0.70
▲ UP 7.69% (0.05)

KEY STATISTICS

Market Cap$31.32 M
52w High$1.87
52w Low$0.50
Dividend Yield—
Frequency—
P/E-0.90
Volume124.08K
Shares Out.44.74M

COMPANY

LEADERSHIP

Heather Getz
CHIEF EXECUTIVE
Heather Getz

COMPENSATION 2026

Salary$402,548
Stock Awards$0
Incentive Plan Pay$156,994
All Other Comp.$0
Total$2,399,605

ABOUT

SECTOR
Healthcare
WENT PUBLIC
November 7, 2019
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
218

PRICE TARGET

Target High$20.00
Target Low$1.25
Target Median$3.00
Target Consensus$8.25

UPCOMING EARNINGS

DateNov 12, 2026
DayThursday
Rev. Est.$20.04M
NOV
12
THU

PRICE

$0.70 ▲ UP 7.69% (+$0.05)
$0.66$0.67$0.699:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM0.70

About TELA Bio, Inc.

https://www.telabio.com ↗

TELA Bio, Inc. develops soft-tissue reconstruction products, including OviTex matrices for hernia repair and reconstructive surgery, primarily marketed in the U.S. to improve clinical outcomes.

INDUSTRY

Medical - Devices

A PRODUCT TELA BIO, INC. IS KNOWN FOR

OviTex PRS Reinforced Tissue Matrix (Large Sizes)
OviTex PRS Reinforced Tissue Matrix (Large Sizes)

TELA Bio's advanced biologic scaffold, made from ovine rumen and polymer sutures, now offers larger sizes to support complex soft tissue repairs in plastic and reconstructive surgery.

COMPETITORS

COMPETITOR
BAX COMPARE
IART COMPARE
MDXG COMPARE
ORGO COMPARE
SYK COMPARE

Revenue by Geography

MapREGIONQ3-2025Q4-2025Q1-2026Q2-2026
UNITED STATES— — — $15.5M
NonUS$3M $3.5M ▲$3.7M ▲$3.8M ▲

ETFS HOLDING THIS STOCK

ETFS HOLDING
12
LISTED HERE
2
RANKED BY POSITION SIZE
VTS.AX
0.00% · 1.1M
PQ
PQSG
0.19% · 1.8K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
61.04%
HOLDERS
52
TOP 12 OF 52 · RANKED BY POSITION SIZE
Essex Woodlands Management, Inc.
7.7M sh · $4.78M
Nantahala Capital Management, LLC
5.1M sh · $3.19M
Silverarc Capital Management, LLC
2.8M sh · $4.15M
Stonepine Capital Management, LLC
2.6M sh · $1.62M
Vanguard Group Inc
1.8M sh · $2.16M
Ubs Group AG
1.5M sh · $1.77M
Dafna Capital Management LLC
1.4M sh · $893.44K
Perkins Capital Management Inc
1.4M sh · $879.36K
Citigroup Inc
750.0K sh · $465K
Velan Capital Investment Management LP
747.4K sh · $1.11M
Pentwater Capital Management LP
724.9K sh · $1.08M
Sio Capital Management, LLC
636.3K sh · $394.51K

RATINGS SNAPSHOT

Overall rating: B-

DCFROEROAD/EP/EP/B
Discounted Cash Flow5
Return On Equity5
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score2

INSIDER TRADES

★
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Getz Heather C
Purchase · 12.5K shares
2026-08-17
★
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Getz Heather C
Purchase · 15.0K shares
2026-08-14
★
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Getz Heather C
Purchase · 1.4M shares
2026-08-03
★
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Getz Heather C
Purchase · 1.0M shares
2026-08-03

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 2
MARKET OUTPERFORM 1
NEUTRAL 1
4 GRADES IN THE LAST 12 MONTHS
Citizens MARKET OUTPERFORM Canaccord Genuity BUY Lake Street BUY Piper Sandler NEUTRAL

SECTORS PEERS

PEERPRICE
SPRB$60.78COMPARE
EQ$2.39COMPARE
OTLK$0.64COMPARE
CUE$27.88COMPARE
NRXP$3.55COMPARE
SRTS$3.52COMPARE
MDAI$1.57COMPARE
CTSO$0.34COMPARE